Amerikanische Gesellschaft für Hirudotherapie

Regulation Agency for Medical and Pharmaceutical Activities of Georgia

Georgia RAMA · Georgia · europe

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Georgia's Regulation Agency for Medical and Pharmaceutical Activities (Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs) — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national pharmaceutical and medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Georgia
Leech status
unregulated
Last ASH review
2026-05-27

Relevant Regulation Codes

  • Georgian Law on Medicinal Products and Pharmaceutical Activities
  • Georgian national medical device regulatory framework (progressively aligning with EU MDR 2017/745 as part of EU accession process)
  • Georgian framework for traditional and folk medicine where applicable

Prescriber Requirements

  • Ministry of Health–licensed physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Agency registration as applicable; Georgian-language labelling required by national law (with English-language supplementary information where relevant). Standard cold-chain conditions.

Import/Export Rules

Ministry of Health and National Food Agency clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Universal Healthcare Programme (UHCP) coverage depends on inpatient bundling; outpatient hirudotherapy is generally not separately reimbursed.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; Georgia sits at the regulatory interface of the post-Soviet space and the EU accession trajectory. The contemporary statutory pathway for hirudotherapy has not been independently mapped by ASH.

Related Jurisdictions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.